Related Experiment Videos
Mammalian RNAi for the masses
1Department of Pathology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA. yang_shi@hms.harvard.edu
Trends in Genetics : TIG
|December 21, 2002
Summary
RNA-mediated interference (RNAi) now works in mammalian cells using small interfering RNAs (siRNAs). A new DNA vector method enables stable gene inhibition for extended gene function studies.
Area of Science:
- Molecular Biology
- Genetics
Background:
- RNA-mediated interference (RNAi) was previously limited to specific organisms like plants and C. elegans.
- Gene function analysis in mammals was challenging before the advent of RNAi.
Purpose of the Study:
- To adapt RNAi technology for use in mammalian systems.
- To explore novel methods for delivering small interfering RNAs (siRNAs) into mammalian cells.
- To enable stable and prolonged gene function studies in higher eukaryotes.
Main Methods:
- Utilizing in vitro synthesized 21- to 23-nucleotide double-stranded RNAs as siRNAs.
- Developing a DNA vector-based delivery system for siRNAs into mammalian cells.
Main Results:
- Successfully demonstrated RNAi in mammalian cells using siRNAs.
- Developed a cost-effective DNA vector strategy for siRNA delivery.
- Achieved stable target gene inhibition, facilitating long-term gene function analysis.
Conclusions:
- RNAi is now a viable technology for studying gene function in mammalian systems.
- DNA vector-based siRNA delivery offers a stable and economical alternative for mammalian RNAi.
- This advance significantly impacts the study of gene function in higher eukaryotes.